Encourage Timely and Flexible FDA Review of Rare Disease Therapies like DCA

Despite recent success, few mitochondrial disease patients have access to an approved therapy. That has to change.  Ask Congress to ensure the FDA can meet the urgent, unmet medical need of our community, like the pending New Drug Application for DCA to treat PDCD. 

To start, simply: 

1. Enter your address below to match with your representative and hit Submit.

2. On the next page, a pre-populated letter will come up with an opening, body, and outro. Each section can be customized to your situation!

3. Once you're done, simply fill in your contact info and hit send. It's that easy! 

 

Target Search